Raymond James & Associates »

Peregrine Pharmaceuticals shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $68k 10k 6.70
2023-12-31 $66k 10k 6.50
2023-09-30 $105k 11k 9.44
2023-06-30 $196k 14k 13.97
2023-03-31 $270k 14k 18.76
2022-12-31 $198k 14k 13.77
2022-09-30 $275k 14k 19.12
2022-06-30 $219k 14k 15.23
2022-03-31 $293k 14k 20.37
2021-12-31 $420k 14k 29.21
2021-09-30 $225k 10k 21.62
2021-06-30 $267k 10k 25.65
2021-03-31 $190k 10k 18.25
2020-12-31 $121k 11k 11.56
2020-09-30 $80k 11k 7.64
2020-06-30 $69k 11k 6.59
2020-03-31 $53k 11k 5.06